LLY Competitors & Alternatives
Compare Eli Lilly and Company with similar stocks in the same industry
Drug Manufacturers - General
LLY
Main Stock$1111.19
Tradestie Score
52
Market Cap
$739.95B
P/E Ratio
39.1
Revenue Growth
0.6%
Analyst Upside
+9.7%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$238.86
|
$448.07B | 26.5 | 63 | Compare |
|
ABBV
ABBVIE INC.
|
$234.40
|
$431.71B | 106.1 | 66 | Compare |
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$407.87
|
$315.45B | 30.2 | 55 | Compare |
|
NVO
Novo-Nordisk A/S
|
$47.26
|
$262.92B | 10.1 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$179.93
|
$261.56B | 26.3 | 51 | Compare |
|
NVS
Novartis AG
|
$153.05
|
$254.99B | 21.0 | 59 | Compare |
|
ABT
Abbott Laboratories
|
$90.35
|
$232.30B | 24.8 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$119.05
|
$225.13B | 32.1 | 59 | Compare |
|
AMGN
Amgen Inc
|
$347.13
|
$160.70B | 23.5 | 64 | Compare |
|
PFE
Pfizer Inc.
|
$24.90
|
$154.70B | 19.2 | 59 | Compare |
More LLY Analysis
Data updated: Jun 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry